Skip to main content

Site notifications

Notice for glofitamab (Roche Products Pty Limited)

Active ingredients
glofitamab
Date of review outcome
Lapse date
Type
Orphan drug
Indication
Treatment of diffuse large B-cell lymphoma
Therapeutic area
Haematology

Help us improve this page